Delek US (NYSE:DK - Get Free Report) had its target price lifted by equities research analysts at Scotiabank from $20.00 to $33.00 in a report issued on Thursday,Benzinga reports. The firm presently has a "sector perform" rating on the oil and gas company's stock. Scotiabank's price target suggests a potential downside of 7.06% from the company's current price.
DK has been the topic of several other reports. Raymond James Financial raised their price target on shares of Delek US from $26.00 to $33.00 and gave the stock an "outperform" rating in a research note on Tuesday, September 9th. Wall Street Zen raised shares of Delek US from a "sell" rating to a "hold" rating in a research note on Friday, October 3rd. Bank of America lifted their target price on shares of Delek US from $14.00 to $24.00 and gave the stock an "underperform" rating in a research note on Wednesday, September 3rd. Citigroup reaffirmed a "neutral" rating and set a $30.00 target price (up from $15.00) on shares of Delek US in a research note on Wednesday, July 16th. Finally, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Delek US in a research note on Wednesday. Three analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $28.69.
Check Out Our Latest Stock Report on Delek US
Delek US Price Performance
Shares of NYSE:DK traded up $0.88 during midday trading on Thursday, hitting $35.51. The company's stock had a trading volume of 395,377 shares, compared to its average volume of 1,740,326. The business's 50 day simple moving average is $27.70 and its 200 day simple moving average is $21.61. The company has a debt-to-equity ratio of 10.48, a quick ratio of 0.50 and a current ratio of 0.80. The company has a market cap of $2.14 billion, a P/E ratio of -2.89 and a beta of 1.01. Delek US has a 12-month low of $11.02 and a 12-month high of $35.62.
Delek US (NYSE:DK - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The oil and gas company reported ($0.56) earnings per share for the quarter, topping the consensus estimate of ($0.92) by $0.36. The firm had revenue of $2.76 billion for the quarter, compared to the consensus estimate of $2.68 billion. Delek US had a negative net margin of 7.11% and a negative return on equity of 79.27%. The company's revenue for the quarter was down 16.4% on a year-over-year basis. During the same period last year, the firm posted ($0.92) earnings per share. On average, analysts forecast that Delek US will post -5.5 EPS for the current year.
Insider Buying and Selling at Delek US
In other Delek US news, CFO Robert G. Wright sold 7,135 shares of Delek US stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $29.24, for a total transaction of $208,627.40. Following the completion of the sale, the chief financial officer directly owned 48,294 shares in the company, valued at $1,412,116.56. This trade represents a 12.87% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.80% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Delek US
A number of institutional investors have recently made changes to their positions in the stock. Ion Asset Management Ltd. increased its position in shares of Delek US by 1.8% during the second quarter. Ion Asset Management Ltd. now owns 3,743,890 shares of the oil and gas company's stock valued at $79,296,000 after acquiring an additional 67,490 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. increased its position in shares of Delek US by 113.5% during the second quarter. Harel Insurance Investments & Financial Services Ltd. now owns 1,601,777 shares of the oil and gas company's stock valued at $33,926,000 after acquiring an additional 851,458 shares during the last quarter. Allianz Asset Management GmbH increased its position in shares of Delek US by 25.2% during the second quarter. Allianz Asset Management GmbH now owns 1,051,066 shares of the oil and gas company's stock valued at $22,262,000 after acquiring an additional 211,791 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Delek US by 35.3% in the first quarter. Charles Schwab Investment Management Inc. now owns 1,037,599 shares of the oil and gas company's stock valued at $15,637,000 after purchasing an additional 270,792 shares in the last quarter. Finally, Northern Trust Corp grew its holdings in shares of Delek US by 9.2% in the first quarter. Northern Trust Corp now owns 987,086 shares of the oil and gas company's stock valued at $14,875,000 after purchasing an additional 83,246 shares in the last quarter. 97.01% of the stock is currently owned by institutional investors and hedge funds.
About Delek US
(
Get Free Report)
Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Delek US, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delek US wasn't on the list.
While Delek US currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
